Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Atria Investments Inc

Atria Investments Inc cut its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 31.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 29,545 shares of the company's stock after selling 13,731 shares during the quarter. Atria Investments Inc's holdings in Ryan Specialty were worth $1,962,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Signaturefd LLC increased its position in shares of Ryan Specialty by 12.3% in the third quarter. Signaturefd LLC now owns 1,347 shares of the company's stock valued at $89,000 after buying an additional 148 shares in the last quarter. UMB Bank n.a. increased its position in shares of Ryan Specialty by 5.2% in the third quarter. UMB Bank n.a. now owns 5,224 shares of the company's stock valued at $347,000 after buying an additional 256 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Ryan Specialty by 96.4% in the second quarter. GAMMA Investing LLC now owns 605 shares of the company's stock valued at $35,000 after buying an additional 297 shares in the last quarter. Hollencrest Capital Management purchased a new position in shares of Ryan Specialty in the third quarter valued at $25,000. Finally, CHICAGO TRUST Co NA increased its position in Ryan Specialty by 10.3% during the 3rd quarter. CHICAGO TRUST Co NA now owns 4,838 shares of the company's stock worth $321,000 after purchasing an additional 450 shares in the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the business's stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $65.15, for a total transaction of $2,280,250.00. Following the completion of the transaction, the director now owns 9,115 shares in the company, valued at $593,842.25. The trade was a 79.34 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of the business's stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares of the company's stock, valued at $884,236.54. This represents a 54.42 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 94,193 shares of company stock worth $6,208,493. 11.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Barclays assumed coverage on Ryan Specialty in a research report on Wednesday, September 4th. They set an "overweight" rating and a $76.00 price objective for the company. Wells Fargo & Company raised their price target on Ryan Specialty from $63.00 to $70.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 10th. BMO Capital Markets raised Ryan Specialty from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $65.00 to $75.00 in a research note on Tuesday, September 24th. UBS Group raised their price target on Ryan Specialty from $67.00 to $76.00 and gave the stock a "buy" rating in a research note on Tuesday, August 13th. Finally, Bank of America raised their price target on Ryan Specialty from $75.00 to $84.00 and gave the stock a "buy" rating in a research note on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $70.33.

Ryan Specialty Stock Down 0.4 %

Shares of NYSE:RYAN traded down $0.29 during mid-day trading on Friday, hitting $70.62. 186,767 shares of the company traded hands, compared to its average volume of 871,750. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a 52-week low of $41.49 and a 52-week high of $73.10. The firm's 50 day simple moving average is $68.14 and its 200 day simple moving average is $61.66. The firm has a market cap of $18.49 billion, a P/E ratio of 92.05, a PEG ratio of 1.63 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. During the same period in the previous year, the business earned $0.32 EPS. Ryan Specialty's revenue for the quarter was up 20.5% compared to the same quarter last year. On average, equities analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current year.

Ryan Specialty Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be issued a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.62%. Ryan Specialty's dividend payout ratio (DPR) is 57.14%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.